JPH10512876A - コルチコステロイドを含有するリポソーム - Google Patents

コルチコステロイドを含有するリポソーム

Info

Publication number
JPH10512876A
JPH10512876A JP8522703A JP52270396A JPH10512876A JP H10512876 A JPH10512876 A JP H10512876A JP 8522703 A JP8522703 A JP 8522703A JP 52270396 A JP52270396 A JP 52270396A JP H10512876 A JPH10512876 A JP H10512876A
Authority
JP
Japan
Prior art keywords
composition according
formula
composition
compound
phosphatidylcholine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8522703A
Other languages
English (en)
Japanese (ja)
Inventor
ウィリアム テイラー,ピーター
キャサリン マース,ジャネット
Original Assignee
ノバルティス アクチェンゲゼルシャフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノバルティス アクチェンゲゼルシャフト filed Critical ノバルティス アクチェンゲゼルシャフト
Publication of JPH10512876A publication Critical patent/JPH10512876A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP8522703A 1995-01-24 1996-01-17 コルチコステロイドを含有するリポソーム Pending JPH10512876A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9501286.0A GB9501286D0 (en) 1995-01-24 1995-01-24 Pharmaceutical compositions and preparations thereof
GB9501286.0 1995-01-24
PCT/GB1996/000083 WO1996022764A1 (en) 1995-01-24 1996-01-17 Liposomes containing a corticosteroid

Publications (1)

Publication Number Publication Date
JPH10512876A true JPH10512876A (ja) 1998-12-08

Family

ID=10768424

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8522703A Pending JPH10512876A (ja) 1995-01-24 1996-01-17 コルチコステロイドを含有するリポソーム

Country Status (10)

Country Link
EP (1) EP0859598A1 (no)
JP (1) JPH10512876A (no)
CN (1) CN1169115A (no)
AU (1) AU4396196A (no)
CA (1) CA2210482A1 (no)
CZ (1) CZ234297A3 (no)
FI (1) FI973049A7 (no)
GB (1) GB9501286D0 (no)
NO (1) NO973401D0 (no)
WO (1) WO1996022764A1 (no)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006508990A (ja) * 2002-11-26 2006-03-16 エムシーエス マイクロ キャリア システムズ ゲーエムベーハー 自己形成リン脂質ゲル
JP2007302684A (ja) * 2000-12-04 2007-11-22 Novartis Ag 有機化合物

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9263298A (en) 1997-08-18 1999-03-08 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Phospholipid analogue compounds
GB9912639D0 (en) * 1999-05-28 1999-07-28 Britannia Pharmaceuticals Ltd Improvements in and relating to treatment of respiratory conditions
GB2359749B (en) * 1998-11-26 2004-05-05 Britannia Pharmaceuticals Ltd Anti-asthmatic combinations comprising surface active phospholipids
US7364749B1 (en) 1999-05-27 2008-04-29 Euro-Celtique, S.A. Preparations for the application of anti-infective and/or anti-inflammatory agents
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
AU2001241045A1 (en) * 2000-03-09 2001-09-17 Kissei Pharmaceutical Co. Ltd. Preventive or therapeutic drugs for eye diseases
ATE549014T1 (de) * 2006-09-05 2012-03-15 Q P Corp Prostaglandin-fettemulsion, verfahren zu ihrer herstellung, verfahren zu ihrer stabilisierung und emulgierendes mittel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4607028A (en) * 1983-08-18 1986-08-19 Ciba-Geigy Corporation Novel carboxylic acid esters
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
US5043165A (en) * 1988-12-14 1991-08-27 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007302684A (ja) * 2000-12-04 2007-11-22 Novartis Ag 有機化合物
JP2006508990A (ja) * 2002-11-26 2006-03-16 エムシーエス マイクロ キャリア システムズ ゲーエムベーハー 自己形成リン脂質ゲル

Also Published As

Publication number Publication date
WO1996022764A1 (en) 1996-08-01
EP0859598A1 (en) 1998-08-26
FI973049L (fi) 1997-07-18
NO973401L (no) 1997-07-23
AU4396196A (en) 1996-08-14
CZ234297A3 (en) 1997-10-15
NO973401D0 (no) 1997-07-23
CA2210482A1 (en) 1996-08-01
MX9705592A (es) 1997-11-29
GB9501286D0 (en) 1995-03-15
FI973049A0 (fi) 1997-07-18
FI973049A7 (fi) 1997-07-18
CN1169115A (zh) 1997-12-31

Similar Documents

Publication Publication Date Title
US6045828A (en) Powders for inhalation
US5043165A (en) Novel liposome composition for sustained release of steroidal drugs
JP3042867B2 (ja) 呼吸疾患治療薬
US4906476A (en) Novel liposome composition for sustained release of steroidal drugs in lungs
EP1259225B1 (en) Process of dehydration/rehydration for making liposomes
CA1315678C (en) Alpha-tocopherol based vesicles
EP0223831B1 (en) Liposome inhalation method and system
JP2911814B2 (ja) リポソーム性の水中分散する経口投与可能な固体乾燥治療用処方の製造方法
JPWO1991010431A1 (ja) 脂肪乳剤
JP2002510311A (ja) トコフェロールにより安定化された吸引用プロリポソーム粉末
GB2256139A (en) Liposome preparations containing terbinafine
JPH01501228A (ja) 高濃度リポソーム処理方法
JPH10512876A (ja) コルチコステロイドを含有するリポソーム
CN113456591B (zh) 糖基聚醚类化合物脂质体及其制备方法和药物
WO1987005803A1 (en) COMPOSITIONS OF LIPOSOMES AND beta2-RECEPTOR ACTIVE SUBSTANCES
MXPA97005592A (en) Pharmaceutical compositions containing corticosteroids and preparation of mys
JP3074731B2 (ja) 脂肪乳剤
MXPA97004406A (en) Proliposomas powders for inhalac
JPWO1991007962A1 (ja) 脂肪乳剤
MXPA99011675A (en) Proliposome powders for inhalation stabilised by tocopherol